Author

Tomoko Ichiki

Observed names: Ichiki, Tomoko, T Ichiki, T. Ichiki, Tomoki Ichiki

Institutions: Sapporo Medical University, Kagawa University

Observed institutions: Kagoshima University, American Heart Association, Mayo Clinic, Sapporo Medical University, Shiga University of Medical Science, Kagawa University, National Hospital Organization, Kagoshima Medical Center, International University of Health and Welfare Narita Hospital, International University of Health and Welfare

ORCID: 0000-0002-7451-4675

Observed ORCID: 0000-0002-7451-4675

OpenAlex ID: A5074323945

The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide

2010 · S. Jeson Sangaralingham, Brenda K. Huntley, et al. · Hypertension · 117

Corin Is Present in the Normal Human Heart, Kidney, and Blood, with Pro–B-Type Natriuretic Peptide Processing in the Circulation

2010 · Tomoko Ichiki, Brenda K Huntley, et al. · Clinical Chemistry · 103

Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells

2010 · Michihisa Jougasaki, Tomoko Ichiki, et al. · British Journal of Pharmacology · 98

PDF

Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection

2011 · Fernando L. Martin, Paul M. McKie, et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 84

Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study

2011 · Paul M. McKie, Alessandro Cataliotti, et al. · Mayo Clinic Proceedings · 67

PDF

Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis

2012 · Tomoko Ichiki, Guido Boerrigter, et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 66

CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart

2012 · Fernando L. Martin, S. Jeson Sangaralingham, et al. · PLoS ONE · 65

PDF

Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: Regulation and therapeutic implications

2014 · Tomoko Ichiki, John A. Schirger, et al. · Journal of Molecular and Cellular Cardiology · 59

BNP Molecular Forms and Processing by the Cardiac Serine Protease Corin

2013 · Tomoko Ichiki, Brenda K. Huntley, et al. · Advances in clinical chemistry · 57

Prevalence of childhood obesity from 1978 to 2007 in Japan

2009 · Masao Yoshinaga, Tomoko Ichiki, et al. · Pediatrics International · 55

Pro–B-Type Natriuretic Peptide-1-108 Processing and Degradation in Human Heart Failure

2014 · Brenda K. Huntley, Sharon M. Sandberg, et al. · Circulation Heart Failure · 52

PDF

Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide

2018 · Tomoko Ichiki, Nina Dzhoyashvili, et al. · International Journal of Cardiology · 47

A Novel Atrial Natriuretic Peptide Based Therapeutic in Experimental Angiotensin II Mediated Acute Hypertension

2010 · Paul M. McKie, Alessandro Cataliotti, et al. · Hypertension · 47

Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population

2015 · S. Jeson Sangaralingham, Paul M. McKie, et al. · Hypertension · 44

Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells

2007 · Tomoko Ichiki, Michihisa Jougasaki, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 44

Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen

2016 · S. Jeson Sangaralingham, Bing H. Wang, et al. · Peptides · 43

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

2017 · Rika Kawakami, Candace Y.W. Lee, et al. · Clinical Pharmacology & Therapeutics · 39

PDF

Cardiac Micro–Computed Tomography Imaging of the Aging Coronary Vasculature

2012 · S. Jeson Sangaralingham, Erik L. Ritman, et al. · Circulation Cardiovascular Imaging · 38

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics

2014 · Paul M. McKie, Alessandro Cataliotti, et al. · Journal of the American Heart Association · 35

PDF

Atrial Natriuretic Peptide ― Old But New Therapeutic in Cardiovascular Diseases ―

2017 · Tomoko Ichiki, John C. Burnett Jr · Circulation Journal · 33

PDF

Pro–Atrial Natriuretic Peptide

2015 · Tomoko Ichiki, Brenda K. Huntley, et al. · JACC Heart Failure · 33

PDF

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancingin vivoandex vivoactions

2015 · Candace Y.W. Lee, Brenda K. Huntley, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 32

PDF

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts

2019 · Yang Chen, Ye Zheng, et al. · Journal of Molecular and Cellular Cardiology · 31

Endothelial permeability in vitro and in vivo: Protective actions of ANP and omapatrilat in experimental atherosclerosis

2013 · Tomoko Ichiki, Ririko Izumi, et al. · Peptides · 27

Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide

2019 · Laura M.G. Meems, Ingrid A. Andersen, et al. · Hypertension · 26

Works count: 145

Citation count: 1,662

H-index: 26

I10-index: 37